house · trading 2015-09-22 → 2015-09-22
*Notional-weighted price return on disclosed buys, marked to the latest close — open positions, per-share (share counts aren't disclosed, so this is price performance, not realized $ P&L).
| Date | Ticker | Type | Amount | Est. price | Latest close | Return |
|---|---|---|---|---|---|---|
| 2015-09-22 | GSK | SELL | $1K–$15K | $38.69 | $52.50 2026-06-26 | 0.0% rt |
| 2015-09-22 | GSK | BUY | $1K–$15K | $38.69 | $52.50 2026-06-26 | +35.7% |
| 2015-09-22 | CSCO | SELL | $1K–$15K | $25.14 | $118.97 2026-06-25 | -373.2% exit |
| 2015-09-22 | CSCO | BUY | $1K–$15K | $25.14 | $118.97 2026-06-25 | +373.2% |
| 2015-09-22 | CCL | SELL | $1K–$15K | $49.79 | $29.07 2026-06-26 | +41.6% exit |
| 2015-09-22 | CCL | BUY | $1K–$15K | $49.79 | $29.07 2026-06-26 | -41.6% |
Return: buys are marked to the latest close (open); sells tagged rt are realized round-trips vs a prior disclosed buy; exit = timing (how the stock moved after the sale, seller's perspective).
| Member | Shared tickers |
|---|---|
| Hon. James B. Renacci | 3 · CCL, CSCO, GSK |
| Hon. Mike Kelly | 2 · CSCO, GSK |
| Hon. Kenny Marchant | 2 · CSCO, GSK |
| Hon. Fred Upton | 2 · CSCO, GSK |
| Hon. David P. Roe | 2 · CSCO, GSK |
| Hon. Peter Welch | 2 · CSCO, GSK |
| Hon. Debbie Dingell | 2 · CCL, CSCO |
| Hon. Rohit Khanna | 2 · CSCO, GSK |
| Hon. David Kustoff | 2 · CSCO, GSK |
| Hon. Josh Gottheimer | 2 · CCL, GSK |
| Hon. E. Scott Rigell | 2 · CCL, GSK |
| Hon. K. Michael Conaway | 2 · CSCO, GSK |